Sue Siegel leads two of GE’s growth and innovation initiatives as CEO, GE Ventures & healthymagination. GE Ventures invests in and partners with the start-up ecosystem across Healthcare, Energy, Software, and Advanced Manufacturing. Healthymagination harnesses innovation and partnership inside and outside GE to improve the quality, access and affordability of healthcare. Sue has more than 30 years of experience in corporate and venture capital. Previously, as a financial VC, Sue led investments in personalized medicine, digital health, and life sciences at Silicon Valley-based Mohr Davidow Ventures. Before venture capital, she drove strategy and technology development as well as new market growth at Bio-Rad, DuPont, Amersham, and Affymetrix (NASDAQ: AFFX). As President and a Board Member of Affymetrix, Sue led the company’s transformation from a pre-revenue start up to a global, multi-billion dollar market cap genomics leader.